SEPP1 Levels in Differnet Glucose Tolerance Status Clinical Trial
Official title:
Human Selenoprotein P Concentration With Glucose Tolerance Status
| NCT number | NCT01258426 |
| Other study ID # | SEPP1(DM) |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | December 10, 2010 |
| Last updated | December 10, 2010 |
| Verified date | December 2010 |
| Source | Korea University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Repuclic of Korea: korea Food and Drug Administration |
| Study type | Observational |
Recently, seslenium(Se) has known as important regulator in metabolic status, lipid profile, atherosclerosis progression. SEPP1(selenoprotein P1)is a secreted protein from mainly liver. This protein is used as an index of selenium nutritional status. The association between the concentration of SEPP1(selenoprotein P1) in normal glucose tolerance,impaired glucose tolerance, type 2 diabetes is still a matter of debate. This cross sectional study will evaluate whether glucose status is matter in SEPP1 level.
| Status | Completed |
| Enrollment | 0 |
| Est. completion date | |
| Est. primary completion date | |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Both |
| Age group | 20 Years to 80 Years |
| Eligibility |
Inclusion Criteria: - 20-80 years old - Not severe medical condition Exclusion Criteria: - metformin, insulin using type 2 diabetes |
Observational Model: Case Control, Time Perspective: Cross-Sectional
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Korea University |